BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xuan Yuan HN, Kim HS, Park GR, Ryu JE, Kim JE, Kang IY, Kim HY, Lee SM, Oh JH, Yoon EL, Jun DW. Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease via necroptosis-independent pathway. World J Gastroenterol 2025; 31(6): 96782 [PMID: 39958438 DOI: 10.3748/wjg.v31.i6.96782]
URL: https://www.wjgnet.com/1948-9358/full/v31/i6/96782.htm
Number Citing Articles
1
Yue Xi, Dong Guo, Shi Li, Jie-Yu Guo, Xing-Zhen Chen, Jing-Feng Tang, Ce-Fan Zhou. Targeting mixed lineage kinase domain-like protein's non-necroptosis role: A new horizon in anti-inflammatory therapy for alcoholic liver diseaseWorld Journal of Gastroenterology 2025; 31(13): 104546 doi: 10.3748/wjg.v31.i13.104546
2
Ming-Xing Liang, Ying Zhou, Su-Qun Li, Wan-Sheng Xiang, Zong-Qin Pan, Ying-Hua Chen, Yi-Huai He. Mixed lineage kinase domain-like protein in liver diseases: Cell-type-specific functions and dual rolesWorld Journal of Gastroenterology 2025; 31(14): 104523 doi: 10.3748/wjg.v31.i14.104523